This is a table of named entities, their types, and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel. Please keep in mind that named-entity extraction is not as accurate as more generic parts-of-speech extraction. Unusual results will appear here.
| entity | type | frequency |
|---|---|---|
| covid | ORG | 549 |
| covid 19 | ORG | 263 |
| sars | DISEASE | 135 |
| coronavirus | TAXON | 128 |
| pneumonia | DISEASE | 124 |
| infection | DISEASE | 122 |
| china | GPE | 115 |
| sars cov 2 | ORG | 97 |
| copd | ORG | 96 |
| wuhan | GPE | 80 |
| cov | ORG | 77 |
| oxygen | CHEMICAL | 73 |
| tb | ORG | 72 |
| coronavirus | TAXON | 66 |
| csa | ORG | 64 |
| coronavirus disease | DISEASE | 60 |
| viral | TAXON | 54 |
| niv | ORG | 54 |
| italy | GPE | 48 |
| mers cov | ORG | 44 |
| mers | DISEASE | 43 |
| hfno | ORG | 42 |
| iga | ORG | 38 |
| op | ORG | 38 |
| virus | TAXON | 38 |
| death | DISEASE | 35 |
| thrombosis | DISEASE | 33 |
| asthma | DISEASE | 31 |
| coronavirus disease | DISEASE | 31 |
| smoking | CHEMICAL | 29 |
| deaths | DISEASE | 29 |
| critically ill | DISEASE | 29 |
| bal | ORG | 29 |
| hfnc | GPE | 28 |
| human | TAXON | 28 |
| gm | ORG | 27 |
| lco | CHEMICAL | 27 |
| cancer | DISEASE | 24 |
| infections | DISEASE | 23 |
| comorbidity | DISEASE | 23 |
| pe | ORG | 23 |
| nrs | ORG | 23 |
| ards | DISEASE | 23 |
| capa | ORG | 22 |
| pneumonia | DISEASE | 21 |
| li | CHEMICAL | 21 |
| uk | GPE | 21 |
| thrombotic | DISEASE | 21 |
| nicotine | CHEMICAL | 21 |
| tuberculosis | DISEASE | 19 |
| respiratory failure | DISEASE | 19 |
| individuals | TAXON | 19 |
| hypertension | DISEASE | 17 |
| diabetes | DISEASE | 17 |
| angiotensin | CHEMICAL | 17 |
| cpap | ORG | 17 |
| k co | ORG | 16 |
| hypoxaemia | DISEASE | 16 |
| shenzhen | GPE | 16 |
| respiratory distress syndrome | DISEASE | 15 |
| middle east | LOC | 15 |
| pulmonary aspergillosis | DISEASE | 14 |
| vte | ORG | 14 |
| sars cov | ORG | 14 |
| nccid | ORG | 14 |
| k | CHEMICAL | 14 |
| covid 19 | ORG | 14 |
| ics | ORG | 13 |
| eti | ORG | 13 |
| rs | PERSON | 13 |
| inflammation | DISEASE | 13 |
| carbon monoxide | CHEMICAL | 12 |
| igg | ORG | 12 |
| coronavirus pneumonia | DISEASE | 11 |
| asthmatic | DISEASE | 11 |
| hubei | TAXON | 11 |
| covid19 | ORG | 11 |
| jak | ORG | 10 |
| ci | ORG | 10 |
| fio | CHEMICAL | 10 |
| iqr | ORG | 10 |
| peep | ORG | 10 |
| mers cov infection | ORG | 10 |
| fever | DISEASE | 10 |
| lung cancer | DISEASE | 10 |
| obesity | DISEASE | 9 |
| acute respiratory distress syndrome | DISEASE | 9 |
| cancer | PERSON | 9 |
| ace 2 | ORG | 9 |
| respiratory distress syndrome | DISEASE | 8 |
| chronic obstructive pulmonary disease | DISEASE | 8 |
| comorbidity | DISEASE | 8 |
| aspergillosis | DISEASE | 8 |
| cftr | ORG | 8 |
| infected | DISEASE | 8 |
| ncov | ORG | 8 |
| respiratory syndrome | DISEASE | 8 |
| lactate | CHEMICAL | 8 |
| ms | ORG | 7 |
| coronavirus infected pneumonia | DISEASE | 7 |
| d lco | ORG | 7 |
| dni | ORG | 7 |
| dvt | PERSON | 7 |
| europe | LOC | 7 |
| h1n1 | DISEASE | 7 |
| igg igm | ORG | 7 |
| fov | ORG | 7 |
| psi | ORG | 7 |
| malignancy | DISEASE | 7 |
| tuberculosis | DISEASE | 7 |
| opacity | DISEASE | 7 |
| opacities | DISEASE | 7 |
| viral infections | DISEASE | 7 |
| infectious disease | DISEASE | 7 |
| dexamethasone | CHEMICAL | 7 |
| us | GPE | 7 |
| who | ORG | 6 |
| aspergillus | TAXON | 6 |
| cox | PERSON | 6 |
| cyclosporin a | CHEMICAL | 6 |
| eortc | ORG | 6 |
| france | GPE | 6 |
| interferon | ORG | 6 |
| prevalence | ORG | 6 |
| rna | ORG | 6 |
| viral | TAXON | 6 |
| bio aerosol | ORG | 6 |
| acute respiratory syndrome | DISEASE | 6 |
| fungal | TAXON | 6 |
| acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 6 |
| hyperinflammation | DISEASE | 6 |
| heparin | PERSON | 6 |
| nucleic acid | CHEMICAL | 6 |
| fibrosis | DISEASE | 6 |
| cardiovascular diseases | DISEASE | 6 |
| calcium | CHEMICAL | 6 |
| omalizumab | CHEMICAL | 6 |
| igm | ORG | 5 |
| ra | ORG | 5 |
| paris | GPE | 5 |
| malaria | TAXON | 5 |
| mers cov infection | ORG | 5 |
| roc | GPE | 5 |
| jnk | ORG | 5 |
| infection | DISEASE | 5 |
| hape | ORG | 5 |
| irf1 | ORG | 5 |
| iii | ORG | 5 |
| hcw | ORG | 5 |
| coronavirus disease | DISEASE | 5 |
| cxr | ORG | 5 |
| aspergillosis | GPE | 5 |
| aec | ORG | 5 |
| spain | GPE | 5 |
| sepsis | DISEASE | 5 |
| ruxolitinib | CHEMICAL | 5 |
| wuhan china epidemiological | ORG | 5 |
| respiratory diseases | DISEASE | 5 |
| acute lung injury | DISEASE | 5 |
| viruses | TAXON | 5 |
| viral infection | DISEASE | 5 |
| urea | CHEMICAL | 5 |
| the world health organization | ORG | 5 |
| the united states | GPE | 5 |
| sepsis | DISEASE | 5 |
| tocilizumab | CHEMICAL | 5 |
| neutropenia | DISEASE | 5 |
| humans | TAXON | 5 |
| mice | TAXON | 5 |
| animal | TAXON | 5 |
| confusion | DISEASE | 5 |
| angiotensin ii | CHEMICAL | 5 |
| impaired d lco | DISEASE | 5 |
| lung injury | DISEASE | 5 |
| lopinavir ritonavir | CHEMICAL | 4 |
| respiratory syndrome | DISEASE | 4 |
| rt pcr | ORG | 4 |
| ppe | CHEMICAL | 4 |
| new zealand | GPE | 4 |
| np | ORG | 4 |
| no | CHEMICAL | 4 |
| mycobacterium | TAXON | 4 |
| mice | TAXON | 4 |
| map | ORG | 4 |
| bdg | ORG | 4 |
| lactoferrin | PERSON | 4 |
| ldh | ORG | 4 |
| dexamethasone | CHEMICAL | 4 |
| deepak | GPE | 4 |
| death | DISEASE | 4 |
| cna | ORG | 4 |
| cs | ORG | 4 |
| belgium | GPE | 4 |
| acute respiratory syndrome coronavirus 2 sars cov 2 infection | DISEASE | 4 |
| tki | ORG | 4 |
| ai | GPE | 4 |
| asthma exacerbations | DISEASE | 4 |
| lopinavir ritonavir | CHEMICAL | 4 |
| bacterial | TAXON | 4 |
| thrombocytopenia | GPE | 4 |
| the national health commission | ORG | 4 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 4 |
| respiratory syndrome coronavirus | DISEASE | 4 |
| respiratory infections | DISEASE | 4 |
| pulmonary embolism | DISEASE | 4 |
| neutrophil | GPE | 4 |
| mouse | TAXON | 4 |
| venous thromboembolism | DISEASE | 4 |
| journal | ORG | 4 |
| hypercoagulability | DISEASE | 4 |
| human coronavirus | TAXON | 4 |
| hemoptysis | DISEASE | 4 |
| eosinopenia | DISEASE | 4 |
| endotheliitis | DISEASE | 4 |
| cough | DISEASE | 4 |
| corticosteroids | CHEMICAL | 4 |
| comorbid | DISEASE | 4 |
| hypoxia | DISEASE | 4 |
| lombardy | GPE | 3 |
| nhs | ORG | 3 |
| n | ORG | 3 |
| mers cov infections | DISEASE | 3 |
| ii | ORG | 3 |
| li li | CHEMICAL | 3 |
| influenza | ORG | 3 |
| india | GPE | 3 |
| il | PERSON | 3 |
| new york city | GPE | 3 |
| nsclc | ORG | 3 |
| prognosis | ORG | 3 |
| p20 | ORG | 3 |
| pai | ORG | 3 |
| pcr | ORG | 3 |
| pao | ORG | 3 |
| pulmonary aspergillosis | DISEASE | 3 |
| recovery | PERSON | 3 |
| remdesivir | PERSON | 3 |
| respiratory syndrome coronavirus 2 sars | DISEASE | 3 |
| saba | PERSON | 3 |
| hydroxychloroquine | CHEMICAL | 3 |
| hypoxaemia | PERSON | 3 |
| diagnosis | GPE | 3 |
| hubei province | GPE | 3 |
| corticosteroid | GPE | 3 |
| arf | ORG | 3 |
| auc | ORG | 3 |
| asthma | GPE | 3 |
| asthmatic | LOC | 3 |
| balf | ORG | 3 |
| bos | PERSON | 3 |
| clinical characteristics | ORG | 3 |
| colleague | GPE | 3 |
| coronavirus 2019 ncov pneumonia | DISEASE | 3 |
| dst | ORG | 3 |
| hong kong | GPE | 3 |
| sin | DISEASE | 3 |
| drs cherian | PERSON | 3 |
| ecfs | ORG | 3 |
| ecmo | ORG | 3 |
| fda | ORG | 3 |
| fcαri | ORG | 3 |
| gina | ORG | 3 |
| hu | ORG | 3 |
| hangzhou | GPE | 3 |
| sars cov 2 rt pcr | ORG | 3 |
| jingzhou | GPE | 3 |
| solidarity | ORG | 3 |
| influenza | ORG | 3 |
| irritation | DISEASE | 3 |
| lymphopenia | DISEASE | 3 |
| multicentre | PERSON | 3 |
| murine | TAXON | 3 |
| myocardial infarction | DISEASE | 3 |
| myocardial injury | DISEASE | 3 |
| obstructive pulmonary disease | DISEASE | 3 |
| outbreaks | TAXON | 3 |
| pulmonary oedema | DISEASE | 3 |
| respiratory distress | DISEASE | 3 |
| respiratory syndrome coronavirus mers | DISEASE | 3 |
| ribavirin | CHEMICAL | 3 |
| shock | DISEASE | 3 |
| swab | PERSON | 3 |
| swab specimens | PERSON | 3 |
| thrombotic complications | DISEASE | 3 |
| venous thromboembolic | DISEASE | 3 |
| viral pneumonia | DISEASE | 3 |
| vivo | GPE | 3 |
| Ⅲ | PERSON | 3 |
| south africa | GPE | 3 |
| influenza infection | DISEASE | 3 |
| rheumatoid arthritis | DISEASE | 3 |
| infectious diseases | DISEASE | 3 |
| coronary heart disease | DISEASE | 3 |
| sweden | GPE | 3 |
| immunocompromised | DISEASE | 3 |
| tgf | ORG | 3 |
| toronto | GPE | 3 |
| vannes | ORG | 3 |
| virus | TAXON | 3 |
| alveolar damage | DISEASE | 3 |
| bias | CHEMICAL | 3 |
| cardiovascular comorbidities | DISEASE | 3 |
| cisplatin etoposide | CHEMICAL | 3 |
| acute respiratory syndrome sars | DISEASE | 3 |
| coronavirus sars cov | DISEASE | 3 |
| coronavirus infected pneumonia | DISEASE | 3 |
| coronavirus infections | DISEASE | 3 |
| creatine | CHEMICAL | 3 |
| critically unwell | DISEASE | 3 |
| dyspnoea | DISEASE | 3 |
| coronavirus covid | DISEASE | 3 |
| endothelial injury | DISEASE | 3 |
| hypercapnic acute hypoxemic respiratory failure | DISEASE | 3 |
| mycobacterium tuberculosis | CHEMICAL | 2 |
| miracle | ORG | 2 |
| li yi | PERSON | 2 |
| liang wen hua | PERSON | 2 |
| lymphocyte | ORG | 2 |
| mdr tb | PERSON | 2 |
| mers cov infected | DISEASE | 2 |
| middle east respiratory syndrome coronavirus infection | LOC | 2 |
| marco | CHEMICAL | 2 |
| massachusetts | GPE | 2 |
| minzhou | GPE | 2 |
| mycosis | DISEASE | 2 |
| lco v a | CHEMICAL | 2 |
| leung janice | PERSON | 2 |
| ifnβ | DISEASE | 2 |
| laba | CHEMICAL | 2 |
| k d mcalinden | PERSON | 2 |
| jun n | ORG | 2 |
| journal | ORG | 2 |
| jieyang | GPE | 2 |
| janus kinase | PERSON | 2 |
| james chalmers | PERSON | 2 |
| influenza virus infection | ORG | 2 |
| infectious disease | DISEASE | 2 |
| ifnl | ORG | 2 |
| ifn | ORG | 2 |
| nava | ORG | 2 |
| iapa | CHEMICAL | 2 |
| nct04331054 | ORG | 2 |
| s nusair | ORG | 2 |
| neutrophil | GPE | 2 |
| next | ORG | 2 |
| hubei province | GPE | 2 |
| seattle | GPE | 2 |
| sichuan | GPE | 2 |
| saudi arabia | GPE | 2 |
| santé | DISEASE | 2 |
| se | DISEASE | 2 |
| rheumatoid arthritis | DISEASE | 2 |
| respiratory syndrome coronavirus infection | DISEASE | 2 |
| respiratory syndrome coronavirus | DISEASE | 2 |
| respiratory disease | DISEASE | 2 |
| rt pcr testing | ORG | 2 |
| rif | CHEMICAL | 2 |
| results | ORG | 2 |
| rct | ORG | 2 |
| pulmonary embolism | DISEASE | 2 |
| prone | ORG | 2 |
| pierre | DISEASE | 2 |
| pao 2 fio 2 | ORG | 2 |
| ps 2 | ORG | 2 |
| pbsdef | ORG | 2 |
| p18 | ORG | 2 |
| oxygen | CHEMICAL | 2 |
| outcomes | ORG | 2 |
| off | ORG | 2 |
| obesity | DISEASE | 2 |
| op np | ORG | 2 |
| northern italy | LOC | 2 |
| ia | ORG | 2 |
| 4 nucleic acid | CHEMICAL | 2 |
| hepatitis b | DISEASE | 2 |
| hnfo | ORG | 2 |
| caramelo mortality | PERSON | 2 |
| canada | GPE | 2 |
| calu | DISEASE | 2 |
| cf | PERSON | 2 |
| british society of thoracic imaging | ORG | 2 |
| boruta | ORG | 2 |
| bompard et al | PERSON | 2 |
| bicêtre hospital university | ORG | 2 |
| baricitinib | GPE | 2 |
| bacterial | GPE | 2 |
| azithromycin tocilizumab | PERSON | 2 |
| authors | ORG | 2 |
| australia | GPE | 2 |
| aspergillus fumigatus | TAXON | 2 |
| arduino | CHEMICAL | 2 |
| angiotensin ii | PERSON | 2 |
| anakinra | PERSON | 2 |
| american association for bronchology and interventional pulmonology | ORG | 2 |
| alvar agusti | PERSON | 2 |
| alisporivir | CHEMICAL | 2 |
| alanio | PERSON | 2 |
| adjuvant | GPE | 2 |
| acute | GPE | 2 |
| ats | ORG | 2 |
| ace 2 expression | CHEMICAL | 2 |
| 140 | DISEASE | 2 |
| supplementary_methods | DISEASE | 2 |
| carr | PERSON | 2 |
| central hospital | LOC | 2 |
| changsha | GPE | 2 |
| epidemiological | PERSON | 2 |
| h7n9 | GPE | 2 |
| guangzhou medical university | ORG | 2 |
| guangzhou | GPE | 2 |
| guangdong | GPE | 2 |
| guan wei | PERSON | 2 |
| georgia | GPE | 2 |
| g csf | ORG | 2 |
| fungal | PERSON | 2 |
| fatality | DISEASE | 2 |
| fn | ORG | 2 |
| fcs | ORG | 2 |
| f12 | PERSON | 2 |
| england | GPE | 2 |
| coagulopathy | GPE | 2 |
| elshof et al | PERSON | 2 |
| egfr | ORG | 2 |
| ec | ORG | 2 |
| dxy somers delta | ORG | 2 |
| dimar | GPE | 2 |
| diagnostic | GPE | 2 |
| delta | LOC | 2 |
| deaths | DISEASE | 2 |
| date | ORG | 2 |
| coronavirus 2019 ncov infection | DISEASE | 2 |
| comorbidities | ORG | 2 |
| colombi | GPE | 2 |
| spearman | PERSON | 2 |
| middle east respiratory syndrome | LOC | 2 |
| tb disease | DISEASE | 2 |
| pneumonitis | DISEASE | 2 |
| pharyngeal congestion | DISEASE | 2 |
| pathologies | DISEASE | 2 |
| ozone | CHEMICAL | 2 |
| overload | DISEASE | 2 |
| organ failure | DISEASE | 2 |
| obstructive atelectasis | DISEASE | 2 |
| numb | DISEASE | 2 |
| nosocomial infection | DISEASE | 2 |
| neutropenic | DISEASE | 2 |
| n n | ORG | 2 |
| multiorgan disfunction | PERSON | 2 |
| multi organ dysfunction | DISEASE | 2 |
| mmhg | ORG | 2 |
| microvascular injury | DISEASE | 2 |
| microthrombosis | DISEASE | 2 |
| mesothelioma | DISEASE | 2 |
| macrolide | CHEMICAL | 2 |
| lymphocytopenia | DISEASE | 2 |
| lung edema | DISEASE | 2 |
| lung disease | DISEASE | 2 |
| lactoferrin | CHEMICAL | 2 |
| kidney injury | DISEASE | 2 |
| isoniazid | CHEMICAL | 2 |
| interstitial thickening | DISEASE | 2 |
| influenza sars cov | ORG | 2 |
| influenza a pandemic h1n1 | DISEASE | 2 |
| infectious | DISEASE | 2 |
| platinum | CHEMICAL | 2 |
| pneumothorax | DISEASE | 2 |
| hypoxemia | DISEASE | 2 |
| polycythemia vera | PERSON | 2 |
| viremia | DISEASE | 2 |
| ter | ORG | 2 |
| virally | TAXON | 2 |
| viral rna | TAXON | 2 |
| vascular injury | DISEASE | 2 |
| vascular enlargement | DISEASE | 2 |
| tumours | DISEASE | 2 |
| tumour | DISEASE | 2 |
| toxicity | DISEASE | 2 |
| topotecan | CHEMICAL | 2 |
| tofacitinib | CHEMICAL | 2 |
| thrombus | DISEASE | 2 |
| thoracic | GPE | 2 |
| the people s republic of china | GPE | 2 |
| the european respiratory journal | ORG | 2 |
| shortness of breath | DISEASE | 2 |
| siga | ORG | 2 |
| respiratory tract infections | DISEASE | 2 |
| respiratory infection | DISEASE | 2 |
| respiratory disease | DISEASE | 2 |
| pulmonary vascular abnormalities | DISEASE | 2 |
| pulmonary thrombotic microangiopathy | DISEASE | 2 |
| pulmonary thrombosis | DISEASE | 2 |
| pulmonary embolism pe | DISEASE | 2 |
| pulmonary edema | DISEASE | 2 |
| prostacyclin | PERSON | 2 |
| procalcitonin | CHEMICAL | 2 |
| illness | DISEASE | 2 |
| small cell lung cancer | DISEASE | 2 |
| hypovolemic | DISEASE | 2 |
| bronchospasm | DISEASE | 2 |
| breathing speaking coughing or sneezing | DISEASE | 2 |
| bleeding | DISEASE | 2 |
| belt 9 | CHEMICAL | 2 |
| bat | TAXON | 2 |
| bacteria | TAXON | 2 |
| avian | TAXON | 2 |
| atopic dermatitis | DISEASE | 2 |
| anxiety | DISEASE | 2 |
| angiotensin i | CHEMICAL | 2 |
| angiopathy | DISEASE | 2 |
| anaemia | DISEASE | 2 |
| altitude disease | DISEASE | 2 |
| airway inflammation | DISEASE | 2 |
| airflow obstruction | DISEASE | 2 |
| adenovirus | TAXON | 2 |
| acute respiratory infection | DISEASE | 2 |
| acute respiratory failure | DISEASE | 2 |
| acute pulmonary embolism | DISEASE | 2 |
| wuhan jinyintan hospital | ORG | 2 |
| wuhan clinical characteristics | ORG | 2 |
| wheezing | ORG | 2 |
| wenzhou medical university | ORG | 2 |
| viruses | TAXON | 2 |
| tuberculosis tuberculosis | ORG | 2 |
| the first people s hospital | ORG | 2 |
| hypotension | DISEASE | 2 |
| thromboembolic disease | DISEASE | 2 |
| bronchogram | DISEASE | 2 |
| zhong nan | PERSON | 2 |
| burn | DISEASE | 2 |
| denosumab | CHEMICAL | 2 |
| hypercoagulable | DISEASE | 2 |
| hypercapnia | GPE | 2 |
| carbon monoxide d lco | CHEMICAL | 2 |
| hypocapnia | GPE | 2 |
| hydroxychloroquine chloroquine | CHEMICAL | 2 |
| hydroxychloroquine | CHEMICAL | 2 |
| hvx5m2bx | DISEASE | 2 |
| hepatitis b | DISEASE | 2 |
| ferritin | LOC | 2 |
| febrile neutropenia | DISEASE | 2 |
| etoposide | CHEMICAL | 2 |
| emphysema | DISEASE | 2 |
| disease | DISEASE | 2 |
| house | TAXON | 2 |
| cystic fibrosis | DISEASE | 2 |
| coagulopathy | DISEASE | 2 |
| cardiogenic oedema | DISEASE | 2 |
| cardiac diseases | DISEASE | 2 |
| chen | CHEMICAL | 2 |
| chronic respiratory diseases | DISEASE | 2 |
| chest tightness | DISEASE | 2 |
| coronary heart diseases | DISEASE | 2 |
| coronavirus 2019 covid | DISEASE | 2 |
| coronavirus severe acute respiratory syndrome coronavirus 2 sars cov | DISEASE | 2 |
| covid19risk | CHEMICAL | 2 |
| cavitation | DISEASE | 2 |
| italy ethics logistics | ORG | 1 |
| israel | GPE | 1 |
| jacques harrois anatole | PERSON | 1 |
| italy s | GPE | 1 |
| j j smit lidwien a | CHEMICAL | 1 |
| j rello | PERSON | 1 |
| jl | ORG | 1 |
| jacob joseph alexander daniel | DISEASE | 1 |
| jacob joseph alexander daniel baillie | PERSON | 1 |
| jan feb | PERSON | 1 |
| james b ehrmann stephan | PERSON | 1 |
| james buchan | PERSON | 1 |
| jingzhou city | GPE | 1 |
| jilin province | GPE | 1 |
| janus | LOC | 1 |
| janus kinase jak | PERSON | 1 |
| jean louis langelot marie lineau | PERSON | 1 |
| ji xiao bin li li jie zhi jun li | PERSON | 1 |
| invasive mechanical ventilation | ORG | 1 |
| jiashan | GPE | 1 |
| iran | GPE | 1 |
| infection negative nasopharyngeal | ORG | 1 |
| intracellular | ORG | 1 |
| imported infectious diseases | DISEASE | 1 |
| igg igm treatments | ORG | 1 |
| igm iga | ORG | 1 |
| jixi | PERSON | 1 |
| igmbecame igg igm | ORG | 1 |
| ile de france | PERSON | 1 |
| image lab | ORG | 1 |
| imaging | GPE | 1 |
| immune | LOC | 1 |
| immunotherapy | ORG | 1 |
| individual participant data ipd meta | ORG | 1 |
| interstitial abnormalities | DISEASE | 1 |
| infection negative nasopharyngeal and oropharyngeal swabs | DISEASE | 1 |
| infections | DISEASE | 1 |
| influenza infection | DISEASE | 1 |
| institutional review boards | ORG | 1 |
| intensive care society | ORG | 1 |
| intensive care society association of anaesthetists | ORG | 1 |
| intensive care unit a report of thromboelastography findings | ORG | 1 |
| intensive care unit capacity in low income countries a systematic review | ORG | 1 |
| interim | ORG | 1 |
| jinzhong pingyao | PERSON | 1 |
| lara scala | PERSON | 1 |
| jonathan bicanic tihana | PERSON | 1 |
| jonathan m sumner tom houben rein m g j | PERSON | 1 |
| lancet infectious diseases | DISEASE | 1 |
| lanzhou | GPE | 1 |
| larissa hamann | PERSON | 1 |
| latin america | LOC | 1 |
| laura tomaselli | PERSON | 1 |
| lederlin mathieu jouneau stéphane | PERSON | 1 |
| lei shan hong lei chun | PERSON | 1 |
| leica sp5 | LOC | 1 |
| lengshuijiang | GPE | 1 |
| leshan | GPE | 1 |
| lesion | ORG | 1 |
| lessons | PERSON | 1 |
| li jie fink | ORG | 1 |
| li shao qiang | PERSON | 1 |
| li shi | PERSON | 1 |
| liang hong | PERSON | 1 |
| lianjiang county | GPE | 1 |
| lianyungang linqu county | GPE | 1 |
| liberty n 2217978 | ORG | 1 |
| iga deposition | DISEASE | 1 |
| limited | PERSON | 1 |
| lambin philippe | PERSON | 1 |
| lai kefang | PERSON | 1 |
| lmic | ORG | 1 |
| kco | ORG | 1 |
| jorge phan | PERSON | 1 |
| judith gruber achim | PERSON | 1 |
| julien frix | PERSON | 1 |
| jun zhang yan mei yang | PERSON | 1 |
| justin l shah pallav l | PERSON | 1 |
| jérémy richard christian monnet xavier duranteau jacques harrois anatole | CHEMICAL | 1 |
| k co furthermore | ORG | 1 |
| k d | CHEMICAL | 1 |
| k farsalinos | ORG | 1 |
| killerby | ORG | 1 |
| leung | ORG | 1 |
| kai kupferschmidt | PERSON | 1 |
| kaplan meier | PERSON | 1 |
| kappa | ORG | 1 |
| kenneth berka | PERSON | 1 |
| klok et al | PERSON | 1 |
| klok et al describe | PERSON | 1 |
| kolmogorov smirnov | PERSON | 1 |
| kunming medical university laifeng county central hospital | ORG | 1 |
| kupke alexandra meier | PERSON | 1 |
| iga siga | ORG | 1 |
| heederik | DISEASE | 1 |
| identifying | LOC | 1 |
| holistic ai | GPE | 1 |
| hangzhou clinical | ORG | 1 |
| hangzhou huaihua | GPE | 1 |
| hangzhou lin | PERSON | 1 |
| hanshan | CHEMICAL | 1 |
| harbin medical university | ORG | 1 |
| haudebourg | GPE | 1 |
| haut conseil de la santé | PERSON | 1 |
| health care distributed | ORG | 1 |
| health data research | ORG | 1 |
| hebei province henan | GPE | 1 |
| hechi | ORG | 1 |
| hechuan district people s hospital chongqing red cross | ORG | 1 |
| liu ji yang | PERSON | 1 |
| heederik dick j | PERSON | 1 |
| hejin | DISEASE | 1 |
| henan university of science and | ORG | 1 |
| hepatitis b virus reactivation in cancer patients | ORG | 1 |
| hepatitis c | DISEASE | 1 |
| hermann rauch simon | PERSON | 1 |
| hexi university | ORG | 1 |
| high contagiousness and rapid spread | ORG | 1 |
| hamilton medical swiss | ORG | 1 |
| halilaj iva | CHEMICAL | 1 |
| hakonarson hakon liu zhi | PERSON | 1 |
| hcv | ORG | 1 |
| guglielmetti | ORG | 1 |
| guo wen liang liu hao wang tao | PERSON | 1 |
| gupta rishi | PERSON | 1 |
| guy tiphaine créac | PERSON | 1 |
| h1n1_09 | DISEASE | 1 |
| h7n9 infection | DISEASE | 1 |
| h7n9 infections | DISEASE | 1 |
| h7n9 virus | TAXON | 1 |
| hbv | ORG | 1 |
| hfno airvo2 | ORG | 1 |
| hakon | DISEASE | 1 |
| hfno hydro | PERSON | 1 |
| hiv tb | DISEASE | 1 |
| hiv infection | DISEASE | 1 |
| hnfo initiation | DISEASE | 1 |
| hrct | ORG | 1 |
| hu emphysema | DISEASE | 1 |
| hainan | GPE | 1 |
| hainan medical college | ORG | 1 |
| hainan west central hospital | LOC | 1 |
| hitherto | PERSON | 1 |
| honghe | ORG | 1 |
| ideally | ORG | 1 |
| hospital | GPE | 1 |
| humayra | CHEMICAL | 1 |
| hunan | GPE | 1 |
| hunan medical college shenzhen union hospital | ORG | 1 |
| hunan university | ORG | 1 |
| hunan youxian | DISEASE | 1 |
| hyam | CHEMICAL | 1 |
| hydroxychloroquine methylprednisolone | CHEMICAL | 1 |
| hypercoagulability | DISEASE | 1 |
| hypertension diabetes dyslipidemia obesity | DISEASE | 1 |
| hypoxemia | DISEASE | 1 |
| ia corticosteroid | PERSON | 1 |
| ib | ORG | 1 |
| ifn ifnλ | CHEMICAL | 1 |
| ifnα | CHEMICAL | 1 |
| ii iv | ORG | 1 |
| iii iv neutropenia | ORG | 1 |
| inhasco | ORG | 1 |
| ioqs | ORG | 1 |
| irf1 mrna | ORG | 1 |
| isaric | ORG | 1 |
| isth | GPE | 1 |
| humans | TAXON | 1 |
| human alveolar epithelial cells | TAXON | 1 |
| human | TAXON | 1 |
| hospital lu | PERSON | 1 |
| hospital admission | ORG | 1 |
| hospital armed | ORG | 1 |
| hospital chongqing shizhu tujia autonomous county | ORG | 1 |
| hospital gongyi | LOC | 1 |
| hospital guangdong hospital | ORG | 1 |
| hospital hejin | ORG | 1 |
| hospital jiangyou | LOC | 1 |
| hospital jingjiang | LOC | 1 |
| hospital longshan county | ORG | 1 |
| hospital quanzhou county | LOC | 1 |
| huizhou | GPE | 1 |
| hospital zhijiang | LOC | 1 |
| hospitalization | LOC | 1 |
| hospitalizations | ORG | 1 |
| host fitness pathogenic | ORG | 1 |
| hounsfield | ORG | 1 |
| huaibei | ORG | 1 |
| huazhong university of science and technology | ORG | 1 |
| hubei clinical | ORG | 1 |
| huichang | GPE | 1 |
| linshui | PERSON | 1 |
| mcquaid c finn mccreesh | ORG | 1 |
| liu xiao yu | PERSON | 1 |
| ppiase | ORG | 1 |
| o2 | CHEMICAL | 1 |
| op swabs | CHEMICAL | 1 |
| occhipinti mariaelena barisione giovanni barisione emanuela halilaj | PERSON | 1 |
| optimism | DISEASE | 1 |
| ora josuel puxeddu ermanno cavalli francesco | ORG | 1 |
| ottavia | CHEMICAL | 1 |
| ou chun quan li li chen ping yan | PERSON | 1 |
| ou li | PERSON | 1 |
| outcome | ORG | 1 |
| p f ratio | ORG | 1 |
| p02 p05 p08 p17 | ORG | 1 |
| p07 p10 | LOC | 1 |
| p10 | ORG | 1 |
| p13 | PERSON | 1 |
| p14 | ORG | 1 |
| p19 | PERSON | 1 |
| pa | ORG | 1 |
| par | ORG | 1 |
| pbs | ORG | 1 |
| pd | DISEASE | 1 |
| pfa | ORG | 1 |
| nuvoair | ORG | 1 |
| nusair samir | ORG | 1 |
| nucleic | ORG | 1 |
| new york city cardiovascular | GPE | 1 |
| ntcp | ORG | 1 |
| nasal | PERSON | 1 |
| national health commission | ORG | 1 |
| national health commission state administration of | ORG | 1 |
| national health commission of | ORG | 1 |
| national health commission of china 6 sampling | ORG | 1 |
| national heath commission diagnosis | ORG | 1 |
| netherlands | GPE | 1 |
| new york 4 | GPE | 1 |
| ni | CHEMICAL | 1 |
| notwithstanding | ORG | 1 |
| nick joshi indra | PERSON | 1 |
| nitric | PERSON | 1 |
| nitric oxide | CHEMICAL | 1 |
| nomograms | ORG | 1 |
| nonhuman | TAXON | 1 |
| nonsquamous | CHEMICAL | 1 |
| nonsurgical emergency department | ORG | 1 |
| north sichuan medical college | ORG | 1 |
| northern italy baseline | ORG | 1 |
| por | CHEMICAL | 1 |
| pao 2 fio | ORG | 1 |
| liu yang | PERSON | 1 |
| pagliuca tony patel | PERSON | 1 |
| pneumonia an official clinical practice guideline | ORG | 1 |
| pratik dickson robert p | PERSON | 1 |
| preda | ORG | 1 |
| prediction for progression risk in patients | ORG | 1 |
| presenting characteristics comorbidities | ORG | 1 |
| preserving clinical trial integrity | ORG | 1 |
| prevalence of copd | ORG | 1 |
| price laura c mccabe colm garfield ben wort | ORG | 1 |
| probability | ORG | 1 |
| prompt | GPE | 1 |
| protective efficacy | PERSON | 1 |
| pubmed embase | GPE | 1 |
| pulmonary aspergillosis shimabukuro | DISEASE | 1 |
| pulmonary embolism | DISEASE | 1 |
| pulmonary thrombosis | DISEASE | 1 |
| pulmonary vascular endothelialitis thrombosis | DISEASE | 1 |
| pulmonology clinical | ORG | 1 |
| q4w | CHEMICAL | 1 |
| qiang li xiang yang | PERSON | 1 |
| qingdao university | ORG | 1 |
| granulocyte | ORG | 1 |
| pneumonia a longitudinal study ct imaging features | ORG | 1 |
| platinum etoposide | CHEMICAL | 1 |
| pierpaolo | CHEMICAL | 1 |
| paykel healthcare ltd new zealand | ORG | 1 |
| pallav | CHEMICAL | 1 |
| palliative | ORG | 1 |
| pandemic an international collaborative group | ORG | 1 |
| pandemic cassandra s curse | DISEASE | 1 |
| pandemic coronavirus disease | DISEASE | 1 |
| paolo centanni | PERSON | 1 |
| parameters of hemostasis complement | ORG | 1 |
| parravicini | GPE | 1 |
| paykel healthcare | PERSON | 1 |
| pemetrexed | CHEMICAL | 1 |
| philips medical systems | ORG | 1 |
| pemetrexed cisplatin | CHEMICAL | 1 |
| peng peng | PERSON | 1 |
| peng yi xiang | PERSON | 1 |
| people s hospital anyuan | ORG | 1 |
| people s hospital gaolan county | ORG | 1 |
| people s hospital tongchuan mining bureau central hospital | ORG | 1 |
| percentages | ORG | 1 |
| performance characteristics of bilevel pressure ventilators chest | ORG | 1 |
| peter j m parker | PERSON | 1 |
| nox | CHEMICAL | 1 |
| no2 | PERSON | 1 |
| nihr ulch brc | ORG | 1 |
| nice incidence | ORG | 1 |
| m sin don d title | PERSON | 1 |
| m52010 | ORG | 1 |
| mco | CHEMICAL | 1 |
| mdi | ORG | 1 |
| mers cov diabetes mellitus hypertension and death | ORG | 1 |
| mers cov infection saudi arabia impact of comorbidity on fatality rate of patients | ORG | 1 |
| mers cov risk factors for fatal middle east respiratory syndrome coronavirus infections | ORG | 1 |
| mers cov infected calu | DISEASE | 1 |
| mews | ORG | 1 |
| monteil | ORG | 1 |
| mrc gsk | ORG | 1 |
| machine learning | ORG | 1 |
| macrophage | PERSON | 1 |
| mahdad | CHEMICAL | 1 |
| malaria hiv aids | DISEASE | 1 |
| malcolm g | PERSON | 1 |
| management galactomannan | PERSON | 1 |
| manifestations | ORG | 1 |
| mann whitney u | PERSON | 1 |
| marburg virus envelope | TAXON | 1 |
| marc abubakar ibrahim van smeden maarten wong wai keong williams bryan noursadeghi mahdad | PERSON | 1 |
| m niikura | PERSON | 1 |
| lymphocytes | PERSON | 1 |
| lutchman k d | CHEMICAL | 1 |
| lorenzo chiesi sheila | PERSON | 1 |
| liver dysfunction | DISEASE | 1 |
| lodigiani | GPE | 1 |
| lombardy italy | DISEASE | 1 |
| lombardy italy characteristics | ORG | 1 |
| lombardy region | GPE | 1 |
| london | GPE | 1 |
| lonergan and | ORG | 1 |
| long li | PERSON | 1 |
| longnan county | GPE | 1 |
| louis renaud | PERSON | 1 |
| luo jie ye chang jiang zhu shao | PERSON | 1 |
| lovinfosse pierre wang | PERSON | 1 |
| lu | PERSON | 1 |
| lu hai | PERSON | 1 |
| luca guidelli luca guaraldi | ORG | 1 |
| ludger hofmann nina | PERSON | 1 |
| luigi marini john j | PERSON | 1 |
| lumis | PERSON | 1 |
| lung | PERSON | 1 |
| lung cancer | DISEASE | 1 |
| marc chadeau hyam | PERSON | 1 |
| marc ringel | PERSON | 1 |
| marco clini enrico nava stefano | PERSON | 1 |
| montani | CHEMICAL | 1 |
| milano | PERSON | 1 |
| mirko | CHEMICAL | 1 |
| mismatch | DISEASE | 1 |
| mitja boucly | CHEMICAL | 1 |
| models 1 3 | ORG | 1 |
| moderate | ORG | 1 |
| modifications of ct imaging | ORG | 1 |
| mondoni michele | PERSON | 1 |
| montanelli | CHEMICAL | 1 |
| moraxella | PERSON | 1 |
| middle east respiratory syndrome coronavirus spike glycoprotein perlman | LOC | 1 |
| mortality | DISEASE | 1 |
| mouse | TAXON | 1 |
| moutschen | CHEMICAL | 1 |
| mulhouse | CHEMICAL | 1 |
| multicenter study | ORG | 1 |
| multicentre | PERSON | 1 |
| multiple furthermore | ORG | 1 |
| nets | ORG | 1 |
| nfat | ORG | 1 |
| middle east respiratory syndrome treatment with lopinavir ritonavir | LOC | 1 |
| middle east respiratory syndrome coronavirus nonstructural | LOC | 1 |
| mario carlo | PERSON | 1 |
| mechanical | ORG | 1 |
| marnix de bondt charlotte | PERSON | 1 |
| marruchella | PERSON | 1 |
| martina zuccatosta lina | PERSON | 1 |
| mas | ORG | 1 |
| masahiro yang | PERSON | 1 |
| mashan | TAXON | 1 |
| mastermix thermo fisher | ORG | 1 |
| matteo | ORG | 1 |
| measles virus | TAXON | 1 |
| medolla italy | CHEMICAL | 1 |
| middle east respiratory syndrome coronavirus | LOC | 1 |
| medolla italy data | ORG | 1 |
| mehta puja ciurtin | PERSON | 1 |
| mei zhong nanshan | PERSON | 1 |
| mellitus | TAXON | 1 |
| men longitudinal observations | ORG | 1 |
| mexico | GPE | 1 |
| mianyang | CHEMICAL | 1 |
| michel li jiawei li | PERSON | 1 |
| middle east respiratory syndrome a comparative study of clinical presentation and risk | LOC | 1 |
| guangzhou university of traditional | ORG | 1 |
| bloomfield | PERSON | 1 |
| google covid 19 community mobility reports impact | ORG | 1 |
| covid 19 pulmonary vascular endothelialitis thrombosis | DISEASE | 1 |
| bronchoscopies | PERSON | 1 |
| bronchus | ORG | 1 |
| c5b 9 | CHEMICAL | 1 |
| cancer | ORG | 1 |
| cc | CHEMICAL | 1 |
| ccp | DISEASE | 1 |
| ce | CHEMICAL | 1 |
| cip | ORG | 1 |
| cmteg | DISEASE | 1 |
| cogs | ORG | 1 |
| conclusion asthmatics | ORG | 1 |
| copd diabetes hypertension | DISEASE | 1 |
| covid 19 23 | ORG | 1 |
| covid 19 25 | ORG | 1 |
| covid 19 3 | ORG | 1 |
| covid 19 4 | ORG | 1 |
| covid 19 associated respiratory failure respiratory mechanics | ORG | 1 |
| covid 19 comorbidity | ORG | 1 |
| covid 19 lombardy icu network baseline characteristics | ORG | 1 |
| covid 19 mortality | ORG | 1 |
| covid 19 neutrophil | ORG | 1 |
| brittany | GPE | 1 |
| briefly | ORG | 1 |
| bram stoker | PERSON | 1 |
| bi jianping | PERSON | 1 |
| becker | DISEASE | 1 |
| bei liang | PERSON | 1 |
| beijing chizhou | GPE | 1 |
| beijing municipality | GPE | 1 |
| belgian mycosis | ORG | 1 |
| bellin marie | PERSON | 1 |
| bengbu medical college baoding | ORG | 1 |
| berlin | GPE | 1 |
| beurnier antoine | ORG | 1 |
| bi yongyi title novel | CHEMICAL | 1 |
| bouzat pierre pratali | PERSON | 1 |
| bio aerosol dispersion | ORG | 1 |
| bioaerosols | PERSON | 1 |
| qiu shao | PERSON | 1 |
| bodies | PERSON | 1 |
| boehringer ingelheim | LOC | 1 |
| bonaduz | ORG | 1 |
| bos lieuwe | PERSON | 1 |
| bos et al 1 | PERSON | 1 |
| boucly | GPE | 1 |
| covid 19 patients awareness of an increased | ORG | 1 |
| covid 19 tsiodras s escmid study group for respiratory viruses review | ORG | 1 |
| goat | TAXON | 1 |
| covid 19 venous thromboembolism | DISEASE | 1 |
| central hospital anlong | LOC | 1 |
| chai yan | PERSON | 1 |
| challenges of | ORG | 1 |
| chalmers | ORG | 1 |
| characteristics of and important lessons from the coronavirus | ORG | 1 |
| charles river laboratories | ORG | 1 |
| charles salé alexandre | PERSON | 1 |
| chaumais marie | PERSON | 1 |
| chemotherapy | PERSON | 1 |
| chen ru chong | PERSON | 1 |
| chen zhong li | PERSON | 1 |
| chen zi | PERSON | 1 |
| cheng bo xiong shan | PERSON | 1 |
| cheng lin | PERSON | 1 |
| cheng wei tony sin don d | PERSON | 1 |
| chengjiang | PERSON | 1 |
| chest | ORG | 1 |
| chicago | GPE | 1 |
| china a nationwide analysis association | ORG | 1 |
| china acute | ORG | 1 |
| china acute physiology and chronic health evaluation ii score | ORG | 1 |
| centers for disesase control and prevention excess deaths associated | ORG | 1 |
| centers for disease control and prevention | ORG | 1 |
| cells | ORG | 1 |
| calbiochem | ORG | 1 |
| covid 19 aerosol particle | DISEASE | 1 |
| covid 19 malignant | DISEASE | 1 |
| covid ards | DISEASE | 1 |
| covid respiratory monitoring units | ORG | 1 |
| cpk | ORG | 1 |
| crp | ORG | 1 |
| cs ics | ORG | 1 |
| ct manifestations | ORG | 1 |
| cxr three | ORG | 1 |
| calcineurin nfat | ORG | 1 |
| catherine woznitza | PERSON | 1 |
| calcium | CHEMICAL | 1 |
| calvin ge | PERSON | 1 |
| cancold | DISEASE | 1 |
| cancers solides recommandations | DISEASE | 1 |
| cardiovascular | PERSON | 1 |
| cardiovascular safety | PERSON | 1 |
| cardiovascular comorbidities cardiac injury | DISEASE | 1 |
| cardiovascular comorbidity | DISEASE | 1 |
| case fatality rate and characteristics of patients dying in relation | ORG | 1 |
| baseline characteristics | ORG | 1 |
| baseline | ORG | 1 |
| barrier surfaces | ORG | 1 |
| barisione emanuela | CHEMICAL | 1 |
| ace 2 covid 19 | ORG | 1 |
| ace 2 research | ORG | 1 |
| ace 2 systematic | ORG | 1 |
| ace 2 systematic review of | CHEMICAL | 1 |
| ace 2 hrsace 2 reduced | CHEMICAL | 1 |
| ace 2 in | CHEMICAL | 1 |
| ace 2 in their airways | CHEMICAL | 1 |
| ace ace 2 balance | CHEMICAL | 1 |
| ace inhibitors acei | CHEMICAL | 1 |
| acp | ORG | 1 |
| adasyn | ORG | 1 |
| adcc | ORG | 1 |
| adoc | ORG | 1 |
| ai models data | ORG | 1 |
| alv | PERSON | 1 |
| anova | ORG | 1 |
| anzics | ORG | 1 |
| arbs | CHEMICAL | 1 |
| ards lymphopenia | DISEASE | 1 |
| auroc | ORG | 1 |
| acute respiratory disease | DISEASE | 1 |
| ace 2 covid | CHEMICAL | 1 |
| ace | ORG | 1 |
| a british society of thoracic imaging | ORG | 1 |
| 13993003 01708 | CHEMICAL | 1 |
| 1183 13993003 00846 | CHEMICAL | 1 |
| 1183 13993003 00990 | CHEMICAL | 1 |
| 1183 13993003 01104 | CHEMICAL | 1 |
| 1183 13993003 01227 | CHEMICAL | 1 |
| 1183 13993003 01362 | CHEMICAL | 1 |
| 1183 13993003 01875 | CHEMICAL | 1 |
| 1183 13993003 03383 | CHEMICAL | 1 |
| 1183 13993003 03498 | CHEMICAL | 1 |
| 13993003 01361 2020 sha 7d943f3ea1b2a54a926f0f745f384245c8213ab6 doc_id 325565 | CHEMICAL | 1 |
| 13993003 01832 | CHEMICAL | 1 |
| 8 2 130 8 2 | CHEMICAL | 1 |
| 296440 | DISEASE | 1 |
| 301318 | DISEASE | 1 |
| 344641 | DISEASE | 1 |
| 347046 | DISEASE | 1 |
| 349440 | CHEMICAL | 1 |
| 46jzw94p copd | DISEASE | 1 |
| 5 428 deaths | CHEMICAL | 1 |
| 6e908aaa401debce86d240e6228b1c760cd59240 | CHEMICAL | 1 |
| 6z9e5gi6 | DISEASE | 1 |
| acute respiratory failure arf | DISEASE | 1 |
| adenovirus hdpp4 mcherry | PERSON | 1 |
| adult | PERSON | 1 |
| asthma gina | ORG | 1 |
| area vasta emilia | GPE | 1 |
| arginine | CHEMICAL | 1 |
| armstrong james darius | PERSON | 1 |
| arxiv | GPE | 1 |
| aspergillus colonisation | DISEASE | 1 |
| aspergillus diseases | DISEASE | 1 |
| aspergillus flavus | TAXON | 1 |
| aspergillus spp | TAXON | 1 |
| association of respiratory allergy asthma and expression of the sars cov 2 receptor ace2 clinical | ORG | 1 |
| astrazeneca | ORG | 1 |
| anyuan | CHEMICAL | 1 |
| atlanta | GPE | 1 |
| audrey ricordel | PERSON | 1 |
| available | PERSON | 1 |
| azole | CHEMICAL | 1 |
| bnp | ORG | 1 |
| bts guidance | ORG | 1 |
| bw a | ORG | 1 |
| babol north | GPE | 1 |
| barisione | CHEMICAL | 1 |
| arabia | TAXON | 1 |
| anticoagulation | CHEMICAL | 1 |
| adult smartlung | PERSON | 1 |
| analysis | PERSON | 1 |
| africa europe | LOC | 1 |
| air | ORG | 1 |
| air pollution analysis | ORG | 1 |
| airvo2 | GPE | 1 |
| airway obstruction | DISEASE | 1 |
| alkesh khurana | PERSON | 1 |
| amazon | ORG | 1 |
| amedeo | CHEMICAL | 1 |
| american thoracic society infectious disease society of america | ORG | 1 |
| andrea | PERSON | 1 |
| anti vinculin | PERSON | 1 |
| andrea chiocchi marcello sergiacomi giaunluigi federici massimo | PERSON | 1 |
| andrea stiewe | PERSON | 1 |
| angelo gasparini stefano bonifazi | PERSON | 1 |
| angio ct | ORG | 1 |
| angiotensin | CHEMICAL | 1 |
| anjou france | ORG | 1 |
| annalisa negri | PERSON | 1 |
| anthony favaro | PERSON | 1 |
| anti mouse hrp | PERSON | 1 |
| china ct manifestations of two cases | ORG | 1 |
| china characteristics | ORG | 1 |
| china correlation of chest ct | ORG | 1 |
| drs gattinoni | PERSON | 1 |
| endeavours | LOC | 1 |
| endemic human | TAXON | 1 |
| environ health clinical characteristics of coronavirus disease 2019 | ORG | 1 |
| eosinopenia | GPE | 1 |
| epidemic | DISEASE | 1 |
| epithelial | ORG | 1 |
| epithelial injury | DISEASE | 1 |
| er | CHEMICAL | 1 |
| erik hoppe | PERSON | 1 |
| ethics committee of the first affiliated hospital | ORG | 1 |
| etienne marie jevnikar mitja | PERSON | 1 |
| etoposide | CHEMICAL | 1 |
| etoposide cisplatin | CHEMICAL | 1 |
| european centre for disease prevention | ORG | 1 |
| european respiratory journal | ORG | 1 |
| file | ORG | 1 |
| fk 506 | CHEMICAL | 1 |
| florali | ORG | 1 |
| fri | ORG | 1 |
| fabrizio d abramo | PERSON | 1 |
| facciolongo | CHEMICAL | 1 |
| elshof et al s | ORG | 1 |
| elshof | GPE | 1 |
| editorial dr rajendram | PERSON | 1 |
| enacβ epithelial sodium | ORG | 1 |
| du r et al | ORG | 1 |
| du r et al predictors | ORG | 1 |
| dutch belgian mycosis study group | ORG | 1 |
| dutch mycoses study g influenza associated aspergillosis | ORG | 1 |
| dynamic | GPE | 1 |
| e1 | CHEMICAL | 1 |
| e1505 | PERSON | 1 |
| e2 | CHEMICAL | 1 |
| ema | ORG | 1 |
| ers ats | PERSON | 1 |
| editor the coronavirus disease | DISEASE | 1 |
| erspublications absolute | ORG | 1 |
| escmid | ORG | 1 |
| ewas | ORG | 1 |
| early transmission dynamics | ORG | 1 |
| early warning score | PERSON | 1 |
| east africa open | LOC | 1 |
| east midlands nottingham 2 research ethics committee | ORG | 1 |
| eastern france | ORG | 1 |
| editor cancer | DISEASE | 1 |
| faculty of medicine imperial college | ORG | 1 |
| fair allocation of scarce medical resources | ORG | 1 |
| fang zhang fu zhao jin | PERSON | 1 |
| gattinoni | PERSON | 1 |
| gadph ct value group | ORG | 1 |
| gattinoni | ORG | 1 |
| gm csf | ORG | 1 |
| gs | CHEMICAL | 1 |
| gs 5734 | ORG | 1 |
| gsk eminent | CHEMICAL | 1 |
| gtn | CHEMICAL | 1 |
| garmendia | GPE | 1 |
| gattenloehner stefan witte | PERSON | 1 |
| gattinoni luciano | PERSON | 1 |
| g csf potential | ORG | 1 |
| gattinoni et | PERSON | 1 |
| general hospital | ORG | 1 |
| geoff reilly gerry robinson graham | PERSON | 1 |
| germany | GPE | 1 |
| germany 11 | GPE | 1 |
| giles rodrigues jonathan c | PERSON | 1 |
| giovanni | ORG | 1 |
| giovanni battista | PERSON | 1 |
| giulia | PERSON | 1 |
| g73 | ORG | 1 |
| fuzhou dongxiang | PERSON | 1 |
| farré | CHEMICAL | 1 |
| franco | PERSON | 1 |
| fatal | ORG | 1 |
| feasibility | ORG | 1 |
| federica maria girolami | PERSON | 1 |
| fibrosis | DISEASE | 1 |
| fig1 | ORG | 1 |
| figure1a 136 | GPE | 1 |
| fluoprep | CHEMICAL | 1 |
| fluoprep biomérieux | GPE | 1 |
| foshan | GPE | 1 |
| franco cosimo | CHEMICAL | 1 |
| fuzhou | GPE | 1 |
| frank l | CHEMICAL | 1 |
| frank marie | PERSON | 1 |
| frankly | PERSON | 1 |
| front line antiviral protection | ORG | 1 |
| fu li | CHEMICAL | 1 |
| fu li shi yue | PERSON | 1 |
| fu tao liu yu jiang yan yang | PERSON | 1 |
| fungal disease | DISEASE | 1 |
| fungal infections | DISEASE | 1 |
| du r h | ORG | 1 |
| drs cherian et al | PERSON | 1 |
| china epidemiology of imported infectious diseases emerging challenges and opportunities | ORG | 1 |
| dracula | PERSON | 1 |
| confusion | DISEASE | 1 |
| corning | ORG | 1 |
| coronavirus 2 sars cov | DISEASE | 1 |
| coronavirus 2019 | DISEASE | 1 |
| coronavirus disease rems mortality | DISEASE | 1 |
| coronavirus infection | DISEASE | 1 |
| coronavirus infections | DISEASE | 1 |
| coronavirus nonstructural protein | TAXON | 1 |
| coronavirus sars cov | DISEASE | 1 |
| coronavirus infection | DISEASE | 1 |
| coronavirus infections | DISEASE | 1 |
| coughs | ORG | 1 |
| covid | PERSON | 1 |
| covid 19 arterial | ORG | 1 |
| covid 19 arterial hypertension | DISEASE | 1 |
| covid 19 characteristics | ORG | 1 |
| covid 19 infection | DISEASE | 1 |
| covid and lung cancer mesothelioma | DISEASE | 1 |
| crac | DISEASE | 1 |
| creil compiègne | PERSON | 1 |
| critical care utilization | ORG | 1 |
| confronting | ORG | 1 |
| compiègne | CHEMICAL | 1 |
| compassionate use of remdesivir | PERSON | 1 |
| christine marquette | PERSON | 1 |
| china medical university | ORG | 1 |
| china resources | ORG | 1 |
| china sars cov 2 | ORG | 1 |
| china s national health commission | ORG | 1 |
| chongqing analysis | ORG | 1 |
| chongqing medical university | ORG | 1 |
| chongxin | CHEMICAL | 1 |
| chongyi | CHEMICAL | 1 |
| christin | PERSON | 1 |
| chronic | ORG | 1 |
| comorbid hypertension | DISEASE | 1 |
| chronic obstructive pulmonary disease | DISEASE | 1 |
| ciurtin | CHEMICAL | 1 |
| claire cushnan | PERSON | 1 |
| claudia villa | PERSON | 1 |
| clinicaltrials | ORG | 1 |
| cov infection | DISEASE | 1 |
| cov infections | DISEASE | 1 |
| codecasa luigi | PERSON | 1 |
| community | DISEASE | 1 |
| critically ill patients recovery randomised evaluation | ORG | 1 |
| csa alisporivir | CHEMICAL | 1 |
| csa alisporivir alv | LOC | 1 |
| dglucan | CHEMICAL | 1 |
| delong | ORG | 1 |
| decreased k co | ORG | 1 |
| deepak aggarwal 1 | ORG | 1 |
| dengzhou | GPE | 1 |
| departments of pathology and surgery university of giessen | ORG | 1 |
| desheng mei qi han guang | PERSON | 1 |
| detection of sars cov 2 | ORG | 1 |
| dezhou | GPE | 1 |
| dezhou qingyun | PERSON | 1 |
| di marco | CHEMICAL | 1 |
| david w johnson | PERSON | 1 |
| diabetes mellitus hypertension | DISEASE | 1 |
| diagnosis of covid 19 | ORG | 1 |
| dianova | ORG | 1 |
| ding yi liu bin sun wenwu | PERSON | 1 |
| discharge | PERSON | 1 |
| distinct | PERSON | 1 |
| distribution of chest radiographic findings | ORG | 1 |
| district hospital | ORG | 1 |
| doppler | ORG | 1 |
| ddimer | PERSON | 1 |
| david martin françoise | PERSON | 1 |
| csa importantly | ORG | 1 |
| dlco | ORG | 1 |
| cyclophilin inhibitors restrict middle east respiratory syndrome coronavirus via interferon λ | ORG | 1 |
| cyclophosphamide | ORG | 1 |
| cyclophosphamide doxorubicin vincristine | CHEMICAL | 1 |
| d lco d lco v a | CHEMICAL | 1 |
| d lco v a | CHEMICAL | 1 |
| d lutchman | PERSON | 1 |
| d title covid | CHEMICAL | 1 |
| d title smoking ace 2 | CHEMICAL | 1 |
| d225g | ORG | 1 |
| dmso | ORG | 1 |
| david humbert marc | PERSON | 1 |
| dnr | CHEMICAL | 1 |
| dpp4encoding | ORG | 1 |
| dalian medical university the first affiliated hospital of dalian medical university | ORG | 1 |
| dan zhao shengchao | PERSON | 1 |
| dandan li | CHEMICAL | 1 |
| dandan li xi | PERSON | 1 |
| daniel montserrat josep m farré | PERSON | 1 |
| danyang | PERSON | 1 |
| danzhou | GPE | 1 |
| qiu chen chen rongchang | PERSON | 1 |
| zhao lan | PERSON | 1 |
| qu | CHEMICAL | 1 |
| kidney or liver epithelia | DISEASE | 1 |
| infection inflammation | DISEASE | 1 |
| infectious acute exacerbations | DISEASE | 1 |
| inflammation infections | DISEASE | 1 |
| inflammatory cell infiltration | DISEASE | 1 |
| influenza a h7n9 virus infection | DISEASE | 1 |
| influenza complications | DISEASE | 1 |
| influenza like illness | DISEASE | 1 |
| influenza like illness 9 | DISEASE | 1 |
| influenza or coronavirus | DISEASE | 1 |
| injury of posterior pharyngeal wall | DISEASE | 1 |
| interferon | TAXON | 1 |
| interferon beta 1b lopinavir ritonavir | CHEMICAL | 1 |
| interstitial abnormalities | DISEASE | 1 |
| interstitial disorders | DISEASE | 1 |
| interstitial inflammation | DISEASE | 1 |
| interstitial injury | DISEASE | 1 |
| interstitial pneumonia | DISEASE | 1 |
| intimate | CHEMICAL | 1 |
| intrauterine infection | DISEASE | 1 |
| ischemia | DISEASE | 1 |
| isoniazid rifampicin ethambutol | CHEMICAL | 1 |
| infection disability | DISEASE | 1 |
| infection active tuberculosis sequelae | DISEASE | 1 |
| infected cancer | DISEASE | 1 |
| human primates | TAXON | 1 |
| human alveolar epithelial cells | TAXON | 1 |
| human immunodeficiency virus | DISEASE | 1 |
| human immunodeficiency virus hiv covid | DISEASE | 1 |
| human infection | DISEASE | 1 |
| human infections | DISEASE | 1 |
| human lung tissue mers | DISEASE | 1 |
| human metapneumovirus | TAXON | 1 |
| human monocytes | TAXON | 1 |
| human polymorphonuclear cells | TAXON | 1 |
| hypercapnic respiratory failure | DISEASE | 1 |
| infected t | DISEASE | 1 |
| hyperpyrexia | DISEASE | 1 |
| hypertension diabetes | DISEASE | 1 |
| hypertension diabetes cardiopathy disease chronic obstructive pulmonary disease cerebrovascular disease renal disease hepatitis b virus infection | DISEASE | 1 |
| hypertensives | DISEASE | 1 |
| hyperventilation | DISEASE | 1 |
| hypoinflammatory and hyperinflammatory subphenotypes | DISEASE | 1 |
| illness covid | DISEASE | 1 |
| illness whose symptoms | DISEASE | 1 |
| impaired k co | DISEASE | 1 |
| jxigsdzh | CHEMICAL | 1 |
| knockdown | PERSON | 1 |
| cord 275858 | CHEMICAL | 1 |
| labor | DISEASE | 1 |
| min | ORG | 1 |
| min liu xiao | PERSON | 1 |
| min b yellow | PERSON | 1 |
| mitochondrial dysfunction | DISEASE | 1 |
| montelukast | CHEMICAL | 1 |
| multiple organ dysfunction | DISEASE | 1 |
| multiple organ failure | DISEASE | 1 |
| muscle loss | DISEASE | 1 |
| myelofibrosis | DISEASE | 1 |
| myeloid | DISEASE | 1 |
| myeloproliferative neoplasms | DISEASE | 1 |
| myocardial ischaemia ischaemic stroke | DISEASE | 1 |
| m² diabetes | DISEASE | 1 |
| n 4 isolation of a novel coronavirus | ORG | 1 |
| nausea | DISEASE | 1 |
| ncov infection | DISEASE | 1 |
| necrosis | DISEASE | 1 |
| neoplasm 9 | DISEASE | 1 |
| nifedipine | CHEMICAL | 1 |
| nipah virus | TAXON | 1 |
| nitric oxide | CHEMICAL | 1 |
| middle east | LOC | 1 |
| microvascular | ORG | 1 |
| methyllycaconitine | CHEMICAL | 1 |
| lung infection | DISEASE | 1 |
| like illness | DISEASE | 1 |
| limitedalso sars cov | DISEASE | 1 |
| liver damage | DISEASE | 1 |
| liver dysfunction | DISEASE | 1 |
| liver kidney and heart 24 | DISEASE | 1 |
| loss of consciousness blood urea | DISEASE | 1 |
| loss of lung volume | DISEASE | 1 |
| lung cancer e1505 | DISEASE | 1 |
| lung diseases | DISEASE | 1 |
| lung lesions | DISEASE | 1 |
| methanol acetone | CHEMICAL | 1 |
| lung recruitability | DISEASE | 1 |
| lung tissue injury | DISEASE | 1 |
| lupus | DISEASE | 1 |
| major comorbidities viral respiratory infections | DISEASE | 1 |
| major comorbidity | DISEASE | 1 |
| malnutrition | DISEASE | 1 |
| meta | CHEMICAL | 1 |
| metapneumovirus infection | DISEASE | 1 |
| metastasis | DISEASE | 1 |
| human airways ace 2 | DISEASE | 1 |
| host | TAXON | 1 |
| hepatitis d | DISEASE | 1 |
| hepatitis | DISEASE | 1 |
| coronavirus ncov | ORG | 1 |
| coronavirus ncov infection | DISEASE | 1 |
| coronaviruses infections | DISEASE | 1 |
| cough appetite decline | DISEASE | 1 |
| cough fever fatigue myalgia | DISEASE | 1 |
| creatinine | CHEMICAL | 1 |
| critically ill h1n1 | DISEASE | 1 |
| critically ill sars cov 2 infected | DISEASE | 1 |
| cyclosporin a | CHEMICAL | 1 |
| cyclosporine a | CHEMICAL | 1 |
| cytomegalovirus and bacterial sepsis | DISEASE | 1 |
| da coronavirus sars cov 2 | ORG | 1 |
| de8017463e98017036c212095e32b7c0710d6c7b | CHEMICAL | 1 |
| delays | DISEASE | 1 |
| delirium | DISEASE | 1 |
| demographics symptoms disease | DISEASE | 1 |
| desaturation | DISEASE | 1 |
| diabetes mellitus | DISEASE | 1 |
| diarrhea | DISEASE | 1 |
| digestive disturbances | DISEASE | 1 |
| dioxide | CHEMICAL | 1 |
| coronavirus diseases covid | DISEASE | 1 |
| coronavirus sars cov 2 outside of wuhan china | DISEASE | 1 |
| coronavirus sars cov 2 covid 19 ace 2 | DISEASE | 1 |
| cord 339934 g6ufz29l | DISEASE | 1 |
| cord 285897 | DISEASE | 1 |
| cord 290490 u3mkfvxw | DISEASE | 1 |
| cord 296440 | DISEASE | 1 |
| cord 299679 6z9e5gi6 | CHEMICAL | 1 |
| cord 301318 | DISEASE | 1 |
| cord 316058 | DISEASE | 1 |
| cord 325565 | CHEMICAL | 1 |
| cord 333131 | DISEASE | 1 |
| cord 335198 | DISEASE | 1 |
| cord 344641 | DISEASE | 1 |
| coronavirus 2019 ncov | DISEASE | 1 |
| cord 347046 | DISEASE | 1 |
| cord 349440 jxigsdzh | CHEMICAL | 1 |
| cord 350166 loxe11d6 | DISEASE | 1 |
| cord 354290 | DISEASE | 1 |
| cord_uid o5i4a7nl | DISEASE | 1 |
| corona virus disease | DISEASE | 1 |
| coronary artery calcification | DISEASE | 1 |
| coronary heart disease hypertension | DISEASE | 1 |
| coronavirus 2019 disease | DISEASE | 1 |
| diseases | DISEASE | 1 |
| docetaxel | CHEMICAL | 1 |
| doxorubicin a | CHEMICAL | 1 |
| galactomannan gm | GPE | 1 |
| fly | TAXON | 1 |
| fungal co infection | DISEASE | 1 |
| fungal co infections | DISEASE | 1 |
| fungal complications | DISEASE | 1 |
| fungal infection aspergillus flavus | DISEASE | 1 |
| furosemide | CHEMICAL | 1 |
| g invasive | ORG | 1 |
| g obstructive atelectasis | DISEASE | 1 |
| galactomannan | PERSON | 1 |
| gaps | DISEASE | 1 |
| fits | DISEASE | 1 |
| gemcitabine | CHEMICAL | 1 |
| glyceraldehydes 3 phosphate | CHEMICAL | 1 |
| glycopyrrolate formoterol fumarate | CHEMICAL | 1 |
| granulocytic necrotizing | DISEASE | 1 |
| granulomas | DISEASE | 1 |
| granulomas p13 | PERSON | 1 |
| green sao | CHEMICAL | 1 |
| heady | CHEMICAL | 1 |
| hemophagocytic lymphohistiocytosis syndrome | DISEASE | 1 |
| fluticasone salmeterol | CHEMICAL | 1 |
| fibrosis lung disease | DISEASE | 1 |
| dry cough | DISEASE | 1 |
| exacerbators emphysema | DISEASE | 1 |
| e016219 | DISEASE | 1 |
| e20415c2674a7bde2a993aa003c77a183736227e | ORG | 1 |
| edema | DISEASE | 1 |
| embolic lesions lung | DISEASE | 1 |
| emphysema n 1 pulmonary fibrosis | DISEASE | 1 |
| encephalitis | DISEASE | 1 |
| encephalomyelitis | DISEASE | 1 |
| endemic human coronavirus | TAXON | 1 |
| exacerbations | DISEASE | 1 |
| extrapulmonary tb abdominal lymph nodes | DISEASE | 1 |
| fibrin platelets | TAXON | 1 |
| exudate | DISEASE | 1 |
| f3af29a29ff1b774f75206250b7b8eadf7925704 | ORG | 1 |
| failure | DISEASE | 1 |
| febrile neutropaenia | DISEASE | 1 |
| fed | ORG | 1 |
| fever cough fatigue | DISEASE | 1 |
| fever cough headache sore throat shortness | DISEASE | 1 |
| fever headache | DISEASE | 1 |
| fibrin small | PERSON | 1 |
| nitrogen dioxide | CHEMICAL | 1 |
| nitrogen oxide | CHEMICAL | 1 |
| nitrogen oxides nox | CHEMICAL | 1 |
| the american thoracic society and infectious diseases society of america labcorp feature | ORG | 1 |
| the management of cancer patients during the novel coronavirus disease | ORG | 1 |
| the nihr university college london hospitals biomedical research centre | ORG | 1 |
| the national commission on informatics | ORG | 1 |
| the national early warning score news | ORG | 1 |
| the national health commission trial version 5 | ORG | 1 |
| the national health commission trial version 7 chronological | ORG | 1 |
| the national health commission of china | ORG | 1 |
| the oxford university | ORG | 1 |
| the philipps university | ORG | 1 |
| the pulmonology units | ORG | 1 |
| the radiographic assessment of lung edema rale | ORG | 1 |
| the rdrp n | ORG | 1 |
| the regional health agency | ORG | 1 |
| the registry for covid19 emergency recover | ORG | 1 |
| the respiratory department | ORG | 1 |
| the respiratory monitoring units | ORG | 1 |
| the seattle region case series subphenotyping | LOC | 1 |
| the society of cardiovascular computed tomography and society of thoracic radiology epicardial | ORG | 1 |
| the society of thoracic radiology the american college of radiology and rsna radiol cardiothorac imaging false negative tests for sars cov 2 infection challenges and implications | ORG | 1 |
| the surviving sepsis campaign | ORG | 1 |
| the us | ORG | 1 |
| the louisville pneumonia study towards | ORG | 1 |
| the lombardy region italy official | ORG | 1 |
| the italian societies of respiratory medicine | ORG | 1 |
| the european society of clinical microbiology and infectious diseases coronavirus | ORG | 1 |
| the cancold study undiagnosed | ORG | 1 |
| the canadian national population health | ORG | 1 |
| the chinese center for disease control and prevention china | ORG | 1 |
| the creative commons attribution non commercial | ORG | 1 |
| the epidemic s front line | ORG | 1 |
| the european cf society clinical trials network ecfs | ORG | 1 |
| the european respiratory journal bompard | ORG | 1 |
| the european respiratory society | ORG | 1 |
| the european society of cardiology esc prévalence | ORG | 1 |
| the first people s hospital | ORG | 1 |
| the italian respiratory societies joint guidelines | ORG | 1 |
| the fleischner society systematic review of clinicaltrials | ORG | 1 |
| the french asthma and allergy working group | ORG | 1 |
| the global tuberculosis network | ORG | 1 |
| the hazard group | ORG | 1 |
| the isaric who clinical characterisation protocol for severe emerging infection uk isaric ccp | ORG | 1 |
| the infectious diseases society of america diagnosis | ORG | 1 |
| the influenza complications alert network | ORG | 1 |
| the institute of virology philipps university of marburg germany human | ORG | 1 |
| the international severe acute respiratory and emerging infection consortium | ORG | 1 |
| the us national health interview survey | ORG | 1 |
| the united arab emirates histopathology | GPE | 1 |
| the united kingdom | GPE | 1 |
| viral respiratory infections | DISEASE | 1 |
| ventilation obesity | DISEASE | 1 |
| ventilatory defects | DISEASE | 1 |
| vessel pulmonary embolic disease | DISEASE | 1 |
| vi | GPE | 1 |
| vii | ORG | 1 |
| vinorelbine | CHEMICAL | 1 |
| vinorelbine gemcitabine | CHEMICAL | 1 |
| viral cargo | TAXON | 1 |
| viral pneumonitis | DISEASE | 1 |
| virus cargo | TAXON | 1 |
| vasculitis | DISEASE | 1 |
| virus introduction | TAXON | 1 |
| virus isolates | TAXON | 1 |
| vomiting | DISEASE | 1 |
| weakness | DISEASE | 1 |
| wellcontrolled | DISEASE | 1 |
| wheezing | DISEASE | 1 |
| yue ye feng guan li hu dong sheng | PERSON | 1 |
| zoonotic coronaviruses | TAXON | 1 |
| α7 nachr | ORG | 1 |
| venous thrombosis | DISEASE | 1 |
| vascular thrombosis | DISEASE | 1 |
| the united states inhibition | GPE | 1 |
| tissue damage https doi org 10 1183 13993003 02108 | DISEASE | 1 |
| the university of giessen ethics committee | ORG | 1 |
| the university of paris | ORG | 1 |
| the who clinical progression scale | ORG | 1 |
| the world health organisation | ORG | 1 |
| the world health organization 2018 global adult tobacco survey | ORG | 1 |
| the institutional review board | ORG | 1 |
| the upper airways | ORG | 1 |
| thoracic diseases | DISEASE | 1 |
| thrombi | DISEASE | 1 |
| tracheal lacerations | DISEASE | 1 |
| urea nitrogen | PERSON | 1 |
| tracheobronchitis | DISEASE | 1 |
| tremelimumab | CHEMICAL | 1 |
| triweekly | CHEMICAL | 1 |
| tuberculosis deaths | DISEASE | 1 |
| tuberculosis pulmonary sequelae | DISEASE | 1 |
| tumour necrosis | DISEASE | 1 |
| u3mkfvxw | DISEASE | 1 |
| un | ORG | 1 |
| urbanicity | DISEASE | 1 |
| the cmteg for development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with covid | ORG | 1 |
| thank julia | CHEMICAL | 1 |
| non antibiotic | LOC | 1 |
| terizidone | CHEMICAL | 1 |
| postoperative lung function | DISEASE | 1 |
| prednisone | CHEMICAL | 1 |
| premature adjudication | DISEASE | 1 |
| prothrombotic pneumonitis | DISEASE | 1 |
| psychosis | DISEASE | 1 |
| pulmonary disorders | DISEASE | 1 |
| pulmonary edema inflammation | DISEASE | 1 |
| pulmonary embolisms | DISEASE | 1 |
| pulmonary infiltrates | DISEASE | 1 |
| pulmonary injury | DISEASE | 1 |
| pulmonary intravascular coagulopathy | DISEASE | 1 |
| pulmonary microvascular thrombosis | DISEASE | 1 |
| pulmonary parenchymal dysfunction | DISEASE | 1 |
| pulmonary tuberculosis | DISEASE | 1 |
| pyrazinamide | CHEMICAL | 1 |
| qrt pcr | ORG | 1 |
| qing | DISEASE | 1 |
| rabbit | TAXON | 1 |
| reduction of peripheral blood lymphocytes | DISEASE | 1 |
| reductions in social contact | DISEASE | 1 |
| relative reduction | DISEASE | 1 |
| pointsbased | CHEMICAL | 1 |
| pleural blebs rupture | DISEASE | 1 |
| platinum pemetrexed | CHEMICAL | 1 |
| obstructive restrictive diseases | DISEASE | 1 |
| noncontrast noncardiac chest | DISEASE | 1 |
| nonsquamous nsclc cisplatin pemetrexed | DISEASE | 1 |
| noone | CHEMICAL | 1 |
| nut | ORG | 1 |
| obesity hypertension | DISEASE | 1 |
| obesity hypertension diabetes renal failure coronary heart disease | DISEASE | 1 |
| obstruction | DISEASE | 1 |
| obstructive lung disease | DISEASE | 1 |
| obstructive restrictive disease | DISEASE | 1 |
| obstructive restrictive diseases figure 2 | DISEASE | 1 |
| platinum etoposide | CHEMICAL | 1 |
| oedema | DISEASE | 1 |
| organ damage | DISEASE | 1 |
| organ dysfunction | DISEASE | 1 |
| organ injuries | DISEASE | 1 |
| ovarian cancer dyslipidemia | DISEASE | 1 |
| overdiagnosis | DISEASE | 1 |
| pain | DISEASE | 1 |
| panic | DISEASE | 1 |
| pemetrexed | CHEMICAL | 1 |
| renal and neurological p11 | DISEASE | 1 |
| renal diseases | DISEASE | 1 |
| respiratory allergy | DISEASE | 1 |
| sore | DISEASE | 1 |
| shortness of breath ct | DISEASE | 1 |
| sickle cell anaemia | DISEASE | 1 |
| sickle cell disease | DISEASE | 1 |
| skin cancer | DISEASE | 1 |
| sleep apnea syndrome | DISEASE | 1 |
| small airways diseases | DISEASE | 1 |
| smoking alcohol | CHEMICAL | 1 |
| smoking status copd | DISEASE | 1 |
| sodium | CHEMICAL | 1 |
| sore throat | PERSON | 1 |
| sha 2588ca2c30d986414276a12522db3f7d21108966 | CHEMICAL | 1 |
| squamous nsclc | DISEASE | 1 |
| stage disease | DISEASE | 1 |
| status pulmonary sequelae | DISEASE | 1 |
| steroid | CHEMICAL | 1 |
| substance abuse hiv co infection | DISEASE | 1 |
| superinfection | DISEASE | 1 |
| swab s | PERSON | 1 |
| swabs | CHEMICAL | 1 |
| syncytial virus adenovirus | TAXON | 1 |
| shortness of breath 55 | DISEASE | 1 |
| serviceable | DISEASE | 1 |
| respiratory complications | DISEASE | 1 |
| respiratory syndrome coronavirus mers cov infections | DISEASE | 1 |
| respiratory deterioration | DISEASE | 1 |
| respiratory infectious disease | DISEASE | 1 |
| respiratory infectious diseases | DISEASE | 1 |
| respiratory symptoms like cough | DISEASE | 1 |
| respiratory syndrome cov | DISEASE | 1 |
| respiratory syndrome mers | DISEASE | 1 |
| respiratory syndrome sars | DISEASE | 1 |
| respiratory syndrome coronavirus mers cov diabetes mellitus hypertension | DISEASE | 1 |
| respiratory syndrome coronavirus mers cov infection | DISEASE | 1 |
| retinal disease | DISEASE | 1 |
| sereve | CHEMICAL | 1 |
| retinoic acid | CHEMICAL | 1 |
| rhesus macaques | TAXON | 1 |
| rheumatic disease thromboembolism | DISEASE | 1 |
| rhinovirus | TAXON | 1 |
| rog2h4g7 introduction | PERSON | 1 |
| s hospital affiliated hospital | ORG | 1 |
| s hospital guang | PERSON | 1 |
| s mask | PERSON | 1 |
| septic shock | DISEASE | 1 |
| cord 281193 | DISEASE | 1 |
| cord 259453 | DISEASE | 1 |
| qu hui qi liu de chen | PERSON | 1 |
| the lancet china novel coronavirus i research t | ORG | 1 |
| stéphane | CHEMICAL | 1 |
| sun bao | PERSON | 1 |
| sun xi | PERSON | 1 |
| supplementary table | PERSON | 1 |
| suppression of hepatitis c virus replication | ORG | 1 |
| swine | TAXON | 1 |
| switzerland | GPE | 1 |
| systematic | LOC | 1 |
| systematic review of privacy preserving distributed machine learning | ORG | 1 |
| ta | ORG | 1 |
| tb tb | ORG | 1 |
| tb meningeal abscess | DISEASE | 1 |
| tb meningitis | DISEASE | 1 |
| tb mortality | ORG | 1 |
| table 1 | LOC | 1 |
| taiwan | GPE | 1 |
| tang chun li | PERSON | 1 |
| teniposide | CHEMICAL | 1 |
| the british society of thoracic imaging | ORG | 1 |
| the british thoracic society bts | ORG | 1 |
| the chinese national health committee | ORG | 1 |
| studi | PERSON | 1 |
| structure function and antigenicity | ORG | 1 |
| streptococcus | GPE | 1 |
| south yunnan | LOC | 1 |
| sisnieguez | ORG | 1 |
| sitbon | CHEMICAL | 1 |
| sixian hospital | LOC | 1 |
| sleep apnea | DISEASE | 1 |
| smit lidwien | PERSON | 1 |
| smoking | CHEMICAL | 1 |
| sondrio province region lombardy | ORG | 1 |
| song yuan | PERSON | 1 |
| south africa national institute for communicable diseases | ORG | 1 |
| spengler | PERSON | 1 |
| strasbourg france | ORG | 1 |
| stage iv | ORG | 1 |
| standard | ORG | 1 |
| staphylococcus infection | DISEASE | 1 |
| stefanie jarmer | PERSON | 1 |
| stefano | PERSON | 1 |
| storti | PERSON | 1 |
| stoyanova alexandrina | GPE | 1 |
| strapazzon giacomo | PERSON | 1 |
| strasbourg | GPE | 1 |
| the european medical technology industry | ORG | 1 |
| the lancet infectious | ORG | 1 |
| convalescent | DISEASE | 1 |
| the national health commission | ORG | 1 |
| tuberculosis west africa | LOC | 1 |
| tujia | DISEASE | 1 |
| u l | ORG | 1 |
| uk recovery | ORG | 1 |
| ukri mrc | ORG | 1 |
| usa | GPE | 1 |
| undergoing | CHEMICAL | 1 |
| united | ORG | 1 |
| united imaging china | ORG | 1 |
| united kingdom | GPE | 1 |
| united states | GPE | 1 |
| united states factors | GPE | 1 |
| united states percentage | ORG | 1 |
| university of rome tor vergata rome italy clinical characteristics of coronavirus disease | ORG | 1 |
| università | ORG | 1 |
| università degli studi di | DISEASE | 1 |
| upregulated iga | ORG | 1 |
| uptake | ORG | 1 |
| urgent | ORG | 1 |
| va | ORG | 1 |
| vili | DISEASE | 1 |
| tsiodras | CHEMICAL | 1 |
| triweekly | CHEMICAL | 1 |
| triple | ORG | 1 |
| thrombosis | DISEASE | 1 |
| the national health service | ORG | 1 |
| the task force | ORG | 1 |
| the world health organization | ORG | 1 |
| the institutional review board | ORG | 1 |
| theoretically | PERSON | 1 |
| thomas h | PERSON | 1 |
| thoracic imaging | ORG | 1 |
| thoracic society | ORG | 1 |
| thorsten becker | CHEMICAL | 1 |
| thrombotic | DISEASE | 1 |
| trigger | PERSON | 1 |
| tian li | PERSON | 1 |
| tian tang renmin hospital | PERSON | 1 |
| tiantai county | GPE | 1 |
| tiphaine | CHEMICAL | 1 |
| tocilizumab | CHEMICAL | 1 |
| tocilizumab anti il6 | ORG | 1 |
| tongchuan | CHEMICAL | 1 |
| torrego et al | GPE | 1 |
| transparent reporting | PERSON | 1 |
| sinopharm harbin acheng | PERSON | 1 |
| single | ORG | 1 |
| singapore | GPE | 1 |
| simona gentile dr | DISEASE | 1 |
| respiratory covid units | ORG | 1 |
| respiratory distress | DISEASE | 1 |
| respiratory failure | DISEASE | 1 |
| respiratory infections | DISEASE | 1 |
| respiratory intermediate care units | ORG | 1 |
| respiratory intermediate care units despite | ORG | 1 |
| respiratory mechanics and gas exchange | ORG | 1 |
| respiratory monitoring unit | ORG | 1 |
| respiratory syndrome coronavirus 2 a | DISEASE | 1 |
| respiratory syndrome coronavirus infections | DISEASE | 1 |
| respiratory syndrome coronavirus mers | DISEASE | 1 |
| respiratory syndrome coronavirus spike glycoprotein perlman s | DISEASE | 1 |
| respiratory syndrome mers | DISEASE | 1 |
| respiratory syndrome coronavirus mers | DISEASE | 1 |
| respiratory syndrome coronavirus sars | DISEASE | 1 |
| retinoic | PERSON | 1 |
| retinoic acid | CHEMICAL | 1 |
| returns for public funding of medical research with open source hardware open | ORG | 1 |
| rheumatoid | GPE | 1 |
| richard christian monnet | PERSON | 1 |
| risk | PERSON | 1 |
| respiratory covid | DISEASE | 1 |
| respiratory allergy asthma | DISEASE | 1 |
| resources the british society of thoracic | ORG | 1 |
| rachel c | PERSON | 1 |
| qu jie | PERSON | 1 |
| quesiti | GPE | 1 |
| rale | GPE | 1 |
| rcc | DISEASE | 1 |
| rems | DISEASE | 1 |
| rox | CHEMICAL | 1 |
| russo | ORG | 1 |
| russo et al 2 | PERSON | 1 |
| rabbit | TAXON | 1 |
| radiological society of north america expert consensus statement on reporting chest | ORG | 1 |
| rello jordi storti enrico | ORG | 1 |
| raffaele malerba | PERSON | 1 |
| ralf bartenschlager | PERSON | 1 |
| randomized fluid management strategy identification | ORG | 1 |
| rao xiangang guiot | PERSON | 1 |
| raskin jo | PERSON | 1 |
| ray ct | PERSON | 1 |
| recognition | ORG | 1 |
| regeneron | ORG | 1 |
| regression modeling strategies rapid emergency medicine | ORG | 1 |
| risk factors for progression date 2020 04 20 | ORG | 1 |
| roberto dongilli | PERSON | 1 |
| rocco faverio | PERSON | 1 |
| serine arginine protein kinase 1 regulates | PERSON | 1 |
| salton francesco geri pietro confalonieri marco | ORG | 1 |
| samanjit | CHEMICAL | 1 |
| sang ling | PERSON | 1 |
| santa cruz | GPE | 1 |
| sauerhering lucie | PERSON | 1 |
| schauwvlieghe | GPE | 1 |
| sebire neil | PERSON | 1 |
| septic | DISEASE | 1 |
| sergiacomi | CHEMICAL | 1 |
| serrano ricardo | PERSON | 1 |
| sao | ORG | 1 |
| severe acute respiratory syndrome sars cov | ORG | 1 |
| shaanxi clinical characteristics of coronavirus disease 2019 | ORG | 1 |
| shah anand van de veerdonk frank l verweij paul | PERSON | 1 |
| shanghai public health clinical center | ORG | 1 |
| shaodong | PERSON | 1 |
| shenyang institute of automation of the chinese academy of science and first affiliated hospital | ORG | 1 |
| short | PERSON | 1 |
| shuo yang jia wei | PERSON | 1 |
| sigma aldrich enacβ | PERSON | 1 |
| saclay france | ORG | 1 |
| str | CHEMICAL | 1 |
| rome | GPE | 1 |
| sars cov 2 rrt | ORG | 1 |
| royal college of anaesthetists critical | ORG | 1 |
| royal college of physicians | ORG | 1 |
| rubin | PERSON | 1 |
| ruffo tiberi simon sotgiu giovanni | PERSON | 1 |
| sars cov 19 | ORG | 1 |
| sars cov 2 implications | ORG | 1 |
| sars cov 2 sex | ORG | 1 |
| sars cov 2 infection | DISEASE | 1 |
| sars cov 2 outbreak | ORG | 1 |
| sars cov sars cov 2 | ORG | 1 |
| stard | ORG | 1 |
| sars cov infection | DISEASE | 1 |
| sars coronavirus sars cov 2 cell entry | DISEASE | 1 |
| sarscov | TAXON | 1 |
| sclc | DISEASE | 1 |
| sem statistical | ORG | 1 |
| sg a | ORG | 1 |
| spss | ORG | 1 |
| st | ORG | 1 |
| st mode spontaneous breaths | ORG | 1 |
| vaccinia virus | TAXON | 1 |
| van helsing | PERSON | 1 |
| van regenmortel n | ORG | 1 |
| acute chronic respiratory failure | DISEASE | 1 |
| alveolar hemorrhage | DISEASE | 1 |
| an artificial intelligence framework for data driven prediction of coronavirus clinical severity consortium n mc 19 r development and validation of a survival calculator for hospitalized patients | ORG | 1 |
| anecdotebased intuitions | DISEASE | 1 |
| angiotensin 1 7 which | CHEMICAL | 1 |
| angiotensin 1 9 | CHEMICAL | 1 |
| angiotensin aldosterone | CHEMICAL | 1 |
| anomalies | DISEASE | 1 |
| antiphospholipid | DISEASE | 1 |
| antiphospholipid autoimmune | DISEASE | 1 |
| apoptotic cell loss | DISEASE | 1 |
| aspartate | CHEMICAL | 1 |
| asthma thirtyone | DISEASE | 1 |
| asthma asthma | DISEASE | 1 |
| atelectasis | DISEASE | 1 |
| autoimmune diseases | DISEASE | 1 |
| azithromycin | CHEMICAL | 1 |
| azole | CHEMICAL | 1 |
| bacteria co infection | DISEASE | 1 |
| baricitinib | PERSON | 1 |
| bevacizumab | CHEMICAL | 1 |
| bio aerosol generating devices | ORG | 1 |
| alveolar edema | DISEASE | 1 |
| alveolar capillary damage | DISEASE | 1 |
| alveolar abnormalities | DISEASE | 1 |
| acute respiratory syndrome coronavirus 2 infection | DISEASE | 1 |
| acute lung injury co infection | DISEASE | 1 |
| acute pulmonary embolism kidney injury | DISEASE | 1 |
| acute pulmonary embolisms pe | DISEASE | 1 |
| acute respiratory illness | DISEASE | 1 |
| acute respiratory infections | DISEASE | 1 |
| acute respiratory syndrome sars 4 5 d lco v a | DISEASE | 1 |
| acute respiratory syndrome sars coronavirus infection | DISEASE | 1 |
| acute respiratory syndrome coronavirus | DISEASE | 1 |
| acute respiratory syndrome coronavirus 2 disease | DISEASE | 1 |
| acute respiratory syndrome coronavirus sars cov sars cov | DISEASE | 1 |
| alterations obstruction | DISEASE | 1 |
| airway acute respiratory distress syndrome | DISEASE | 1 |
| airway obstruction | DISEASE | 1 |
| al s | GPE | 1 |
| alanine | CHEMICAL | 1 |
| alcohol | CHEMICAL | 1 |
| alkalosis | DISEASE | 1 |
| all references thoracic society of australia | ORG | 1 |
| allergic asthma | DISEASE | 1 |
| allergy | DISEASE | 1 |
| blind multicentre | PERSON | 1 |
| blood urea nitrogen | CHEMICAL | 1 |
| bradykinin | CHEMICAL | 1 |
| clofazimine | CHEMICAL | 1 |
| chloroquine | CHEMICAL | 1 |
| chronic cardiovascular disorders | DISEASE | 1 |
| chronic kidney diseases | DISEASE | 1 |
| chronic lung disease chronic obstructive pulmonary disease | DISEASE | 1 |
| chronic multisystem sequelae | DISEASE | 1 |
| chronic obstructive pulmonary disease copd | DISEASE | 1 |
| circulatory diseases endocrine diseases | DISEASE | 1 |
| cisplatin docetaxel | CHEMICAL | 1 |
| cisplatin pemetrexed | CHEMICAL | 1 |
| coagulation dysfunction | DISEASE | 1 |
| chest eosinopenia | DISEASE | 1 |
| coinfection | DISEASE | 1 |
| colorectal cancer | DISEASE | 1 |
| comorbid diseases | DISEASE | 1 |
| comorbid renal disease | DISEASE | 1 |
| comorbid respiratory diseases | DISEASE | 1 |
| complexity | DISEASE | 1 |
| concomitant pulmonary tuberculosis | DISEASE | 1 |
| conotoxin | CHEMICAL | 1 |
| contamination and fatigue of healthcare workers | DISEASE | 1 |
| chloride | CHEMICAL | 1 |
| chemoreceptor dysfunction | DISEASE | 1 |
| breast cancer | DISEASE | 1 |
| carboplatin paclitaxel | CHEMICAL | 1 |
| bronchiectasis | DISEASE | 1 |
| bronchiolar lymphocytic infiltration | DISEASE | 1 |
| budesonide formoterol | CHEMICAL | 1 |
| cachexia | DISEASE | 1 |
| cancer ccc19 | DISEASE | 1 |
| cancer cancer | DISEASE | 1 |
| cannabis | CHEMICAL | 1 |
| carbon dioxide | CHEMICAL | 1 |
| carbon monoxide d | CHEMICAL | 1 |
| cardiac arrest | DISEASE | 1 |
| cerebrovascular diseases | DISEASE | 1 |
| cardiac disease | DISEASE | 1 |
| cardiac dysfunction | DISEASE | 1 |
| cardiac injury | DISEASE | 1 |
| cardiac toxicity | DISEASE | 1 |
| cardiogenic pulmonary oedema | DISEASE | 1 |
| cardiovascular and cerebrovascular diseases | DISEASE | 1 |
| cardiovascular disease | DISEASE | 1 |
| cavitary disease | DISEASE | 1 |
| cellular damage | DISEASE | 1 |
| acute infection | DISEASE | 1 |
| active bleeding | DISEASE | 1 |
| vancouver | GPE | 1 |
| active tb | DISEASE | 1 |
| wilcoxon | ORG | 1 |
| world health organization | ORG | 1 |
| world health organization clinical progression scale | ORG | 1 |
| world health organization global adult tobacco survey tobacco | ORG | 1 |
| wu caiyun | PERSON | 1 |
| wu guangyao yang pei | PERSON | 1 |
| wu jianlin | PERSON | 1 |
| wu et al | PERSON | 1 |
| wuhan a retrospective observational study eosinophil responses | ORG | 1 |
| wuhan china | LOC | 1 |
| wuhan china clinical | ORG | 1 |
| wuhan clinical | ORG | 1 |
| wuhan clinical characteristics of covid 19 | ORG | 1 |
| wuhan development | ORG | 1 |
| wuhan epidemiological | ORG | 1 |
| wuhan hubei china | ORG | 1 |
| wuhan university | ORG | 1 |
| wuhan university school of health sciences | ORG | 1 |
| wuhu anhui | PERSON | 1 |
| wuyuan county | GPE | 1 |
| xgzp6847005kpg | ORG | 1 |
| west auray | LOC | 1 |
| wenzhou | GPE | 1 |
| wei li jian fu li cai chen | PERSON | 1 |
| vitro | PERSON | 1 |
| varinder | ORG | 1 |
| veerle | CHEMICAL | 1 |
| venous and arterial thromboembolic complications | DISEASE | 1 |
| vincenzo nicastri | PERSON | 1 |
| viraquest inc | ORG | 1 |
| virchow s | GPE | 1 |
| virchow s triad | DISEASE | 1 |
| virus transcription multivesicular | TAXON | 1 |
| vitoria characteristics | ORG | 1 |
| who solidarity | ORG | 1 |
| wei li | PERSON | 1 |
| wang er yi xiao xiao | PERSON | 1 |
| wang lan | PERSON | 1 |
| wang tao | PERSON | 1 |
| wang yajie | PERSON | 1 |
| wanzhou | CHEMICAL | 1 |
| wanzhou district | ORG | 1 |
| washington | GPE | 1 |
| washington state clinical | ORG | 1 |
| wei guo | PERSON | 1 |
| xeljanz | ORG | 1 |
| xiang jie hu yu liu | PERSON | 1 |
| xiangyang central hospital | ORG | 1 |
| zheng pei | PERSON | 1 |
| zeng xiansheng zhang | PERSON | 1 |
| zhang li li qiu | PERSON | 1 |
| zhang nuo fu | PERSON | 1 |
| zhang tao hu | PERSON | 1 |
| zhang wen | PERSON | 1 |
| zhang zhi jiang yu xue | PERSON | 1 |
| zhangye | GPE | 1 |
| zhao yi liang heng | PERSON | 1 |
| zhejiang | GPE | 1 |
| zheng zhi | PERSON | 1 |
| zhang et al 6 | PERSON | 1 |
| zhong bei huang | PERSON | 1 |
| zhong nan shan zhang | PERSON | 1 |
| zhong nan shan | PERSON | 1 |
| zhou | PERSON | 1 |
| zhoushan | GPE | 1 |
| zhuzhou | GPE | 1 |
| zimmermann tobias | PERSON | 1 |
| abnormal chest ct manifestation | DISEASE | 1 |
| aca25c980574d868b03dbb67c89bd4ea7c4758e6 | GPE | 1 |
| zhou et al 5 | PERSON | 1 |
| yuhang district hangzhou | LOC | 1 |
| xiangyang central hospital time | LOC | 1 |
| yx | ORG | 1 |
| xiangyang city hubei | GPE | 1 |
| xiaoshan district | LOC | 1 |
| xinjiang medical university | ORG | 1 |
| xinmi hospital | ORG | 1 |
| xpert | GPE | 1 |
| xpert mtb rif | ORG | 1 |
| xu jin fu | PERSON | 1 |
| xuan anh tuan gozal | PERSON | 1 |
| xuejiao li | PERSON | 1 |
| yan chenggong | PERSON | 1 |
| yuhang district | GPE | 1 |
| yan gu xiao | PERSON | 1 |
| yang dongqin | PERSON | 1 |
| yang hai | PERSON | 1 |
| yang kai wang lingwei li | PERSON | 1 |
| ye feng li shi yue zheng jin | PERSON | 1 |
| years baseline | ORG | 1 |
| yong hu | PERSON | 1 |
| yu hai | PERSON | 1 |
| yuan yu tao wang chong yang yang yong | PERSON | 1 |
| 1183 13993003 00697 | CHEMICAL | 1 |